Marc R. Sarni serves as Executive at HOLLIS EDEN PHARMACEUTICALS INC /DE/, where they oversee executive responsibilities. Since joining the company, Marc R. Sarni has executed 1 insider transactions totaling $27.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 8, 2006 involved purchasing 5,000 shares valued at $27.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 8, 2006 | HEPH | $27.0K | Purchase | 5,000 | $5.40 | Discretionary |
Marc R. Sarni currently holds 5,000 shares of HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc R. Sarni has been a net buyer of HEPH stock. They have purchased $27.0K and sold $0 worth of shares.
Marc R. Sarni's most recent insider trade was on Dec 8, 2006, when they purchased 5,000 shares at $5.40 per share.
Get notified when new Form 4 filings are submitted